GSI 150 Pill - green three-sided
Generic Name: elvitegravir
Pill with imprint GSI 150 is Green, Three-sided and has been identified as Vitekta 150 mg. It is supplied by Gilead Sciences, Inc.
Vitekta is used in the treatment of HIV Infection and belongs to the drug class integrase strand transfer inhibitor. There is no proven risk in humans during pregnancy. Vitekta 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 150
Vitekta
- Generic Name
- elvitegravir
- Imprint
- GSI 150
- Strength
- 150 mg
- Color
- Green
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Integrase strand transfer inhibitor
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-1302 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
hydroxypropyl cellulose,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
water,
sodium lauryl sulfate,
polyvinyl alcohol,
FD&C Blue No. 2,
polyethylene glycol 3350,
ferric oxide yellow,
titanium dioxide,
magnesium silicate
Note: Inactive ingredients may vary.
Related images for "GSI 150"
More about Vitekta (elvitegravir)
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: integrase strand transfer inhibitor
- Breastfeeding
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
